Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying "the evidence to approve the drug wasn't ...
网页链接Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying "the evidence to approve the drug wasn't ...
网页链接
精彩评论